Additional information
Manufacturer |
JRS Pharma |
---|---|
Function |
delayed release, Ready-to-Use enteric coating |
Composition |
Metha-crylic Acid-Ethyl Acrylate copolymer (1:1) |
Dosage Form |
Oral |
€0.00
VIVACOAT® protect E is a white Ready-to-Use enteric coating system based on the globally accepted Metha-crylic Acid-Ethyl Acrylate copolymer (1:1).
VIVACOAT® protect E dissolves at pH values exceeding 5.5. It was developed to protect acid-sensitive APIs against gastric fluids. Likewise, it protects the stomach against irritating actives by delaying drug delivery until the dosage form reaches the small intestine.
The VIVACOAT® protect E system requires no neutralization. This enables an easy one-step reconstitution in water.
Due to the high polymer content of the coating suspension, VIVACOAT® protect E provides short process times.
VIVACOAT® protect E is the ideal solution for delayed release oral dosage forms. Time savings in developement and production are achieved by a simple, fast and robust coating process. Also beneficial are reduced raw material inventory and QC requirements.
We recommend VIVACOAT® PS-1P-041 as sub-coat formulation, if the active ingredient has to be separated from the enteric polymer. For colored tablets, pigmented VIVACOAT® A formulations are ideally suited to be used as a top-coat.
For technical support in lab- and production scale please reach out to JRS Pharma global technical team.
Contact us to obtain your sample of VIVACOAT® protect E.
Manufacturer |
JRS Pharma |
---|---|
Function |
delayed release, Ready-to-Use enteric coating |
Composition |
Metha-crylic Acid-Ethyl Acrylate copolymer (1:1) |
Dosage Form |
Oral |
VIVACOAT® M neo€0.00 |
JRS Pharma | Select options |
VIVACOAT® protect T€0.00 |
JRS Pharma | Select options |